Granules Consumer Health launches packaging facility in US

Hyderabad: Granules India inaugurated and launched its packaging facility through its Granules Consumer Health (GCH) step-down subsidiary which is located in Manassas, Virginia, US.

The facility is over 79,000 square feet and is equipped with packaging lines and clean rooms to package and ship prescription and over-the-counter products across the U.S. market. The facility recently received US FDA approval with zero 483 observations.

Read also: Granules India's step-down subsidiary completes USFDA audit with zero observations

The state-of-the art facility was inaugurated by Ambassador Taranjit Singh Sandhu who serves as India’s Ambassador to the United States. In addition, Ambassador (ret) Atul Keshap, President of the US India Business Council, Mr. Jasjit Singh, Executive Director of Select USA, Mr. Scott Melville, President of the Consumer Healthcare Products Association and Mr. Chris Shorter County Executive of Prince William County were on hand for the inauguration.

“Granules Consumer Health’s packaging facility will improve resilience in our supply chain as well as improving our reaction time. The facility will enable us to meet fast-moving consumer shifts as well as reducing lead times for critical prescriptions products that are in shortage” said Dr. Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India.

The addition of a U.S. packaging facility will result in Granules being among the few pharmaceutical companies to be vertically integrated from API to packaging, Granules has invested approximately $12.5 million into its US packaging facility.

Read also: USFDA nod to Granules India postherpetic neuralgia drug Gabapentin

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. The company manufactures high-quality API, FD, PFI and Speciality Products with a focus on customer centricity. Granules products are distributed to over 300+ customers in regulated and semi-regulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 7 manufacturing facilities out of which 6 are in India and 1 in USA and has regulatory approvals from US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC and HALAL.